Clinical Trial

The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Helicobacter pylori (H. pylori) infection, affecting an estimated 50% of the global population, is a main cause of chronic gastritis, peptic ulcers and gastric cancer. By causing progressive damage to the stomach and may eventually result in gastric atrophy, H. pylori infection has been demonstrated to be responsible for more than 95% of gastric malignancies
Trial Details
NCT Number NCT02933229
Lead Sponsor Shandong University
Conditions Helicobacter Pylori, the Operative Link on Gastric Intestinal Metaplasia, Operative Link on Gastric Intestinal Assessment
Enrollment 300 participants
Start Date 2016-10
Primary Completion 2031-10 (estimated)
Study Completion 2031-10 (estimated)
Updated on ClinicalTrials.gov 2016-10-14